Sort
15,273 grants matching “antimicrobial resistance”
Chicago Prevention and Intervention Epicenter II (CPIE-II)
$5,197,622Mary Katherine Hayden · Rush University Medical Center · U54 · FY2016 · CK
Duke-UNC Prevention Epicenter Program for Prevention of Healthcare-Associated Infections
$5,189,450Deverick John Anderson · Duke University · U54 · FY2016 · CK
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
$5,183,191Dennis L. Kasper · Harvard Medical School · U19 · FY2017 · AI
Southestern Pennsylvania Adult and Pediatric Prevention Epicenter Network
$5,168,935Ebbing Lautenbach · University Of Pennsylvania · U54 · FY2016 · CK
Development of Novel Antimicrobial Resistance Agents
$5,160,457Michael Eichberg · Achaogen, Inc. · N01 · FY2011 · AI
Laboratory for Combinatorial Drug Regimen Design for Resistant and Emerging Pathogens
$5,147,109Linden T Hu · Tufts University Boston · C06 · FY2022 · OD
WASHINGTON UNIVERSITY & BJC EPICENTER FOR PREVENTION OF HEALTHCARE ASSOCIATED INFECTIONS
$5,117,542Victoria J. Fraser · Washington University · U54 · FY2016 · CK
Targeted Clinical Trials for Antimicrobial Resistance
$4,985,063Theoklis Zaoutis · Children'S Hosp Of Philadelphia · N01 · FY2017 · AI
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
$4,937,887Dennis L. Kasper · Harvard Medical School · U19 · FY2014 · AI
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
$4,932,536Dennis L. Kasper · Harvard Medical School · U19 · FY2015 · AI
PREMISE: Pandemic Response Repository through Microbial and Immune Surveillance and Epidemiology
$4,766,197Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Task Order D14: Preclinical, Microbiological, Safety, Toxicology, and Pharmacokinetic Services
$4,750,329Jon Mirsalis · Sri International · N01 · FY2023 · AI
GH16-006: Conducting Communicable Disease Research in Kenya
$4,703,206M Kariuki Njenga · Washington State University · U01 · FY2019 · GH
Vaccine and Treatment Evaluation Units
$4,699,209Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
$4,685,717Dennis L. Kasper · Harvard Medical School · U19 · FY2018 · AI
Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious Diseases
$4,595,632Urs Oschner · Crestone, Inc. · N01 · FY2024 · AI
University of Cape Town Clinical Trials Unit (UCTCTU)
$4,561,851Linda-Gail Bekker · University Of Cape Town · UM1 · FY2019 · AI
BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES
$4,541,026Rick Stevens · · N01 · FY2018 · AI
Advanced Development of Therapeutic Products for Antibiotic Resistant Bacteria
$4,519,619Urs Ochsner · Crestone, Inc. · N01 · FY2022 · AI
STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH ON RESISTANT BACTERIA
$4,500,034Marian Ewell · The Emmes Company, Llc · N01 · FY2019 · AI
The Infectious Diseases Clinical Research Program (IDCRP)
$4,500,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2021 · AI
BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES
$4,490,357Rick Stevens · · N01 · FY2017 · AI
Phase II Clinical Trial to Evaluate a Vaccine Candidate for Gonorrhea
$4,435,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
Chemistry Center for Combatting Antibiotic-Resistant Bacteria (CC4CARB)
$4,361,105Bruce Blough · Research Triangle Institute · N01 · FY2024 · AI
BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES
$4,300,688Rick Stevens · · N01 · FY2015 · AI